Search clinical trials for: High frequency repetitive transcranial magnetic stimulation (rTMS)

Total 1252 results

National Taiwan University Hospital

Not yet recruiting

Effect of Integrated Care Involving Peripheral Functional Magnetic Stimulation for Sarcopenia

Sarcopenia

Taiwan
Huashan Hospital

Unknown

The TMS Treatment for Postoperative Headache in GH Tumor

Headache | Acromegaly | Pituitary Tumor
University of Arkansas

Completed

Neuropathic Pain in Pregnancy

Pain | Pregnancy

United States
Hospices Civils de Lyon

Completed

Conventional Repetitive Transcranial Magnetic Stimulation for Tinnitus Treatment (MagTIN)

Chronic Tinnitus

France
Celgene

Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

Melanoma | Sarcoma | Neoplasms | Lymphoma | Renal Cell Carcinoma | Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Breast Cancer | Small Cell Lung Cancer | Multiple Myeloma | Hodgkin's Lymphoma | Non-Hodgkin's Lymphoma | Non-Small Cell Lung Cancer | Osteosarcoma | Glioblastoma Multiforme | Metastatic Breast... and other conditions

United States
Norgine
Xolomon Tree S.L.

Completed

Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia

Colon Cancer | Colon Disease | Colon Cleansing

Spain, Portugal
National Institute of Neurological Disorders and...

Completed

Physiological Investigations of Movement Disorders

Parkinson's Disease | Movement Disorders | Dystonia | Tic Disorders | Tourette's Syndrome

United States
Bristol-Myers Squibb

Withdrawn

Early Post-marketing Study of Eliquis (Apixaban)

Non-valvular Atrial Fibrillation (NVAF)

Mexico
Merck Sharp & Dohme LLC

Terminated

A Study of MK-2206 in Combination With Trastuzumab and Lapatinib for the Treatment of HER2+ Solid Tumors (MK-2206-015)

Breast Cancer | Advanced Solid Tumors
Massachusetts General Hospital
Patient-Centered Outcomes Research Institute

Completed

Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD (ASCERTAINTRD)

Treatment Resistant Major Depressive Disorder

United States, Canada
Shanghai Zhongshan Hospital

Recruiting

A Multi-center Study of Apixaban(APPROACH)

Evaluate the Safety and Efficacy of Apixaban

China
University of Calgary

Completed

Repeated iTBS Cycloserine Motor Plasticity

Motor Activity

Canada
Bristol-Myers Squibb

Completed

Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN) (AEGEAN)

Non-valvular Atrial Fibrillation

Belgium, France, Italy, Spain, Switzerland, Germany, United Kingdom
Seoul National University Hospital

Completed

NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficiency Undergoing Coronary Catheterization

Kidney Failure

Korea, Republic of
Swiss Federal Institute of Technology
Zurich University of Applied Sciences

Enrolling by invitation

Measuring Dietary Iron Absorption From Edible Insects and Assessing the Effect of Chitin Content on Iron Bioavailability (Study 2) (Sustironable2)

Iron-deficiency

Switzerland
National Institute of Allergy and Infectious Diseases...

Completed

Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants

HIV Infections

United States, South Africa, Brazil, Tanzania, Thailand
University of Calgary

Completed

Cycloserine rTMS Plasticity Augmentation

Motor Activity

Canada
Bristol-Myers Squibb
Pfizer

Completed

Phase 1 Bioavailability Study of Apixaban Solution Formulation Relative to Apixaban Tablets in Healthy Subjects

Healthy Volunteers

United States
Pedro Cahn
Merck Sharp & Dohme LLC

Terminated

Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery

HIV Infections

Argentina
University of Calgary

Completed

Cycloserine rTMS Plasticity Augmentation in Depression

Major Depressive Disorder

Canada
Helsinki University Central Hospital
Merck Sharp & Dohme LLC

Completed

Effect on Liver Fat and Metabolic Parameters When Switching a Protease Inhibitor or Efavirenz to Raltegravir (OBERAL)

Fatty Liver | Metabolic Syndrome | HIV Seropositivity

Finland
Mayo Clinic
Bristol-Myers Squibb; Pfizer

Terminated

Trial of Apixaban vs Warfarin in Reducing Rate of Cognitive Decline, Silent Cerebral Infarcts and Cerebral Microbleeds in Patients With Atrial Fibrillation (ARISTA)

Atrial Fibrillation

United States
Pfizer

Withdrawn

The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study

Atrial Fibrillation

Korea, Republic of
University of Nebraska

Completed

Measurement of Plasma and Intracellular Concentrations of Raltegravir

HIV

United States
Jiangsu Province Nanjing Brain Hospital

Recruiting

Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode (PRHDTDCSTMDE)

Major Depressive Episode

China
Arianna Anticoagulazione Foundation

Terminated

Apixaban for Extended Anticoagulation (APIDULCIS) (APIDULCIS)

Venous Thromboembolism | Anticoagulants

Italy
Merck Sharp & Dohme LLC

Approved for marketing

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)

HIV Infections
Fundación FLS de Lucha Contra el Sida, las Enfermedades...
Merck Sharp & Dohme LLC

Completed

Clinical Trial to Evaluate the Effect of Raltegravir Intensification (1.200 mg QD) on the Gut Microbiota of Chronically HIV-1 Infected Subject Over Time: THE RAGTIME STUDY

HIV

Spain
University of Calgary

Completed

D-Cycloserine+iTBS PK Study

Major Depressive Disorder

Canada
Prof. Wolfgang Janni

Completed

DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs (DETECT III)

HER2-negative Metastatic Breast Cancer | HER2-positive Circulating Tumor Cells

Germany
Hospital San Carlos, Madrid

Recruiting

Amantadine and Transcranial Magnetic Stimulation for Treating Fatigue in Multiple Sclerosis (FETEM)

Multiple Sclerosis | Fatigue

Spain
University of Virginia
National Institute on Alcohol Abuse and Alcoholism (NIAAA); M.D. Anderson Cancer... and other collaborators

Active, not recruiting

New Treatment for Alcohol and Nicotine Dependence

Alcohol Dependence | Nicotine Dependence

United States
Beni-Suef University

Unknown

Efficacy of Apixaban in Malignancy With Deep Venous Thrombosis (DVT)

Deep Vein Thrombosis | Malignancy

Egypt
Imperial College London

Completed

The Raltegravir and Ribavirin Pharmacokinetics (PK) Study

HIV Infections

United Kingdom
Lundquist Institute for Biomedical Innovation at...

Completed

Apixaban Versus Warfarin in the Evaluation of Progression of Atherosclerotic Calcification and Vulnerable Plaque

Atrial Fibrillation

United States
King Abdulaziz University

Not yet recruiting

The Effect of Vitamin C and E Therapy on Restless Leg Syndrome in Patients With End Stage Renal Disease on Haemodialysis

Restless Legs Syndrome | End Stage Renal Disease
Southeast Renal Research Institute
Dialysis Clinic, Inc.

Unknown

Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis

Arteriovenous Fistula Occlusion

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Suspended

Electron Beam Radiotherapy for the Treatment of Refractory Sclerodermatous Chronic Graft Versus Host Disease

Malignant Solid Neoplasm | Hematopoietic and Lymphoid System Neoplasm | Refractory Sclerodermatous Graft Versus Host Disease

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine

Migraine | Headache | Common Migraine | Classic Migraine
Germans Trias i Pujol Hospital
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la...

Completed

Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression

HIV Infections

Spain
University of Catanzaro

Completed

Effects of empagliFlozin on myocardIal metabOlic Rate of glucosE Estimated Through 18FDG PET (FIORE Study) (FIORE)

Type 2 Diabetes | Cardiovascular Risk Factor

Italy
University of Calgary

Completed

Adjunctive D-Cycloserine in Major Depressive Disorder

Major Depressive Disorder

Canada
Bayer
Janssen Research & Development, LLC

Completed

Study to Gather Information How Often Venous Thromboembolism Occurs in Prostate Cancer Patients in Sweden and How This Condition is Treated With Blood Thinners (PRACTISE)

Venous Thromboembolism (VTE)

Sweden
Anne Lindblad
National Institute of Neurological Disorders and Stroke (NINDS); Ortho-McNeil...

Completed

NINDS CRC Chronic Migraine Treatment Trial (CMTT)

Chronic Migraine

United States
Institut National de la Santé Et de la Recherche...
French private agencies

Completed

Primary Prevention Trial of the Health Effects of Antioxidant Vitamins and Minerals.

Healthy

France
Brigham and Women's Hospital

Active, not recruiting

Effects of Vitamin D and Omega-3 Fatty Acids on Infectious Diseases and hCAP18 (VITAL Infection)

Infections | Human Cathelicidin Antimicrobial Peptide (hCAP-18)

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

Epilepsy
National Taiwan University Hospital

Recruiting

The Neuroimage Study of the Neuromuscular Disorders.

Neuromuscular Diseases

Taiwan
Portola Pharmaceuticals

Completed

A Healthy Volunteer Pharmacokinetics (PK)/Pharmacodynamics (PD), Safety and Tolerability Study of Andexanet in Healthy Japanese and Caucasian Subjects

Bleeding

United States
Bankole Johnson

Completed

Combining Medications for the Treatment of Alcohol Dependence: An Inpatient Preliminary Study

Alcoholism

United States

Search clinical trials for: High frequency repetitive transcranial magnetic stimulation (rTMS)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations